CD4 and gastric cancer: The study by Gao et al.43 noted that the percentage of peripheral blood CD4+ T cells expressing PD-1 was significantly higher in treatment-effective advanced GC patients than in treatment-ineffective patients, further emphasizing the key role of CD4+ T cells in immunotherapy efficacy.